Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Anti-Arrhythmia Agents"" wg kryterium: Temat


Tytuł :
Management of atrial fibrillation after transcatheter aortic valve replacement: Challenges and therapeutic considerations.
Autorzy :
Ammar A; Barts Heart Centre, St Bartholomew's Hospital, London, UK; Department of Cardiology, Ain Shams University, Cairo, Egypt. Electronic address: .
Elbatran AI; Department of Cardiology, Ain Shams University, Cairo, Egypt.
Wijesuriya N; Barts Heart Centre, St Bartholomew's Hospital, London, UK.
Saberwal B; Barts Heart Centre, St Bartholomew's Hospital, London, UK.
Ahsan SY; Barts Heart Centre, St Bartholomew's Hospital, London, UK.
Pokaż więcej
Źródło :
Trends in cardiovascular medicine [Trends Cardiovasc Med] 2021 Aug; Vol. 31 (6), pp. 361-367. Date of Electronic Publication: 2020 Jun 27.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Ablation Techniques*/adverse effects
Ablation Techniques*/mortality
Cardiac Catheterization*/adverse effects
Cardiac Catheterization*/instrumentation
Cardiac Catheterization*/mortality
Anti-Arrhythmia Agents/*therapeutic use
Anticoagulants/*therapeutic use
Atrial Fibrillation/*therapy
Platelet Aggregation Inhibitors/*therapeutic use
Transcatheter Aortic Valve Replacement/*adverse effects
Anti-Arrhythmia Agents/adverse effects ; Anticoagulants/adverse effects ; Atrial Fibrillation/diagnosis ; Atrial Fibrillation/mortality ; Atrial Fibrillation/physiopathology ; Comorbidity ; Humans ; Platelet Aggregation Inhibitors/adverse effects ; Prevalence ; Risk Assessment ; Risk Factors ; Stroke/mortality ; Stroke/prevention & control ; Transcatheter Aortic Valve Replacement/mortality ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Anticoagulation and amiodarone for new atrial fibrillation after coronary artery bypass grafting: Prescription patterns and 30-day outcomes in the United States and Canada.
Autorzy :
Matos JD; Division of Cardiology, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Mass.
McIlvaine S; Division of Cardiology, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Mass.
Grau-Sepulveda M; Duke Clinical Research Institute, Durham, NC.
Jawitz OK; Duke Clinical Research Institute, Durham, NC.
Brennan JM; Duke Clinical Research Institute, Durham, NC.
Khabbaz KR; Department of Cardiac Surgery, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Mass.
Sellke FW; Department of Cardiothoracic Surgery, Brown Medical School and Lifespan Hospitals, Providence, RI.
Yeh R; Division of Cardiology, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Mass; Smith Center for Cardiovascular Outcomes Research, Beth Israel Deaconess Medical Center, Boston, Mass.
Zimetbaum P; Division of Cardiology, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Mass; Smith Center for Cardiovascular Outcomes Research, Beth Israel Deaconess Medical Center, Boston, Mass. Electronic address: .
Pokaż więcej
Źródło :
The Journal of thoracic and cardiovascular surgery [J Thorac Cardiovasc Surg] 2021 Aug; Vol. 162 (2), pp. 616-624.e3. Date of Electronic Publication: 2020 Feb 19.
Typ publikacji :
Journal Article; Multicenter Study; Video-Audio Media
MeSH Terms :
Amiodarone/*therapeutic use
Anti-Arrhythmia Agents/*therapeutic use
Anticoagulants/*therapeutic use
Atrial Fibrillation/*drug therapy
Coronary Artery Bypass/*adverse effects
Stroke/*prevention & control
Aged ; Amiodarone/adverse effects ; Anti-Arrhythmia Agents/adverse effects ; Anticoagulants/adverse effects ; Atrial Fibrillation/diagnosis ; Atrial Fibrillation/epidemiology ; Canada/epidemiology ; Clinical Decision-Making ; Female ; Hemorrhage/chemically induced ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Risk Assessment ; Risk Factors ; Stroke/diagnosis ; Stroke/epidemiology ; Time Factors ; Treatment Outcome ; United States/epidemiology
Czasopismo naukowe
Tytuł :
[Cardiac arrhythmias in pregnancy : Epidemiology, clinical characteristics, and treatment options].
Autorzy :
Eckardt L; Klinik für Kardiologie II - Rhythmologie, Universitätsklinikum Münster, Albert-Schweitzer-Campus1, Gebäude A1, 48149, Münster, Deutschland. .
Pokaż więcej
Transliterated Title :
Rhythmusstörungen in der Schwangerschaft : Epidemiologie, Klinik und Therapieoptionen.
Źródło :
Herzschrittmachertherapie & Elektrophysiologie [Herzschrittmacherther Elektrophysiol] 2021 Jun; Vol. 32 (2), pp. 137-144. Date of Electronic Publication: 2021 Mar 19.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Anti-Arrhythmia Agents*/therapeutic use
Arrhythmias, Cardiac*/diagnosis
Arrhythmias, Cardiac*/epidemiology
Arrhythmias, Cardiac*/therapy
Child ; Echocardiography ; Female ; Humans ; Pregnancy
Czasopismo naukowe
Tytuł :
Microcirculatory effects of landiolol: a double-blind, randomised, controlled study after cardiac surgery.
Autorzy :
Ferraris A; Service d'Anesthésie-Réanimation, Hôpital Louis Pradel, Hospices Civils de Lyon, Lyon, France; Laboratoire CarMeN, Inserm UMR 1060, Université Claude Bernard Lyon 1, Lyon, France. Electronic address: .
Jacquet-Lagrèze M; Service d'Anesthésie-Réanimation, Hôpital Louis Pradel, Hospices Civils de Lyon, Lyon, France; Laboratoire CarMeN, Inserm UMR 1060, Université Claude Bernard Lyon 1, Lyon, France.
Cazenave L; Service d'Anesthésie-Réanimation, Hôpital Louis Pradel, Hospices Civils de Lyon, Lyon, France; Laboratoire CarMeN, Inserm UMR 1060, Université Claude Bernard Lyon 1, Lyon, France.
Fornier W; Service d'Anesthésie-Réanimation, Hôpital Louis Pradel, Hospices Civils de Lyon, Lyon, France.
Jalalzai W; Service d'Anesthésie-Réanimation, Hôpital Louis Pradel, Hospices Civils de Lyon, Lyon, France.
Rousseau-Saine N; Service d'Anesthésie-Réanimation, Hôpital Louis Pradel, Hospices Civils de Lyon, Lyon, France.
Allaouchiche B; VetAgro Sup, Université de Lyon, Unité APCSe, Campus Vétérinaire de Lyon, Marcy l'Etoile, France.
Junot S; VetAgro Sup, Université de Lyon, Unité APCSe, Campus Vétérinaire de Lyon, Marcy l'Etoile, France.
Pozzi M; Service de Chirurgie Cardiaque, Hôpital Louis Pradel, Hospices Civils de Lyon, Lyon, France.
Fellahi JL; Service d'Anesthésie-Réanimation, Hôpital Louis Pradel, Hospices Civils de Lyon, Lyon, France; Laboratoire CarMeN, Inserm UMR 1060, Université Claude Bernard Lyon 1, Lyon, France.
Pokaż więcej
Corporate Authors :
Anesthésie-Réanimation Coeur-Thorax-Vaisseaux (ARCOTHOVA) Group
Źródło :
British journal of anaesthesia [Br J Anaesth] 2021 Jun; Vol. 126 (6), pp. e212-e214. Date of Electronic Publication: 2021 Apr 24.
Typ publikacji :
Letter; Randomized Controlled Trial
MeSH Terms :
Cardiac Surgical Procedures*/adverse effects
Cardiopulmonary Bypass*/adverse effects
Adrenergic beta-Antagonists/*therapeutic use
Anti-Arrhythmia Agents/*therapeutic use
Atrial Fibrillation/*prevention & control
Heart Rate/*drug effects
Microcirculation/*drug effects
Morpholines/*therapeutic use
Urea/*analogs & derivatives
Adrenergic beta-Antagonists/adverse effects ; Anti-Arrhythmia Agents/adverse effects ; Atrial Fibrillation/etiology ; Atrial Fibrillation/physiopathology ; Double-Blind Method ; Humans ; Morpholines/adverse effects ; Prospective Studies ; Time Factors ; Treatment Outcome ; Urea/adverse effects ; Urea/therapeutic use
Raport
Tytuł :
COMBINED PHARMACOLOGICAL THERAPY INCLUDING SEVERAL ANTIARRHYTHMIC AGENTS FOR TREATMENT OF DIFFERENT DISORDERS OF CARDIAC RHYTHM.
Autorzy :
Kapustnick Y; Poltava State Medical University, Department of Experimental and Clinical Pharmacology, Сlinical Іmmunology and Аllergology, Ukraine.
Lutsenko R; Poltava State Medical University, Department of Experimental and Clinical Pharmacology, Сlinical Іmmunology and Аllergology, Ukraine.
Sуdorenko A; Poltava State Medical University, Department of Experimental and Clinical Pharmacology, Сlinical Іmmunology and Аllergology, Ukraine.
Pokaż więcej
Źródło :
Georgian medical news [Georgian Med News] 2021 Jun (315), pp. 85-93.
Typ publikacji :
Journal Article
MeSH Terms :
Amiodarone*
Anti-Arrhythmia Agents*/therapeutic use
Arrhythmias, Cardiac/drug therapy ; Humans ; Propafenone ; Sotalol/therapeutic use
Czasopismo naukowe
Tytuł :
Antiarrhythmic drugs-safety and efficacy during pregnancy.
Autorzy :
Fischer AJ; Department of Cardiology III-Adult Congenital and Valvular Heart Disease, University Hospital Muenster, Albert-Schweitzer-Str. 33, 48149, Münster, Germany. .
Diller GP; Department of Cardiology III-Adult Congenital and Valvular Heart Disease, University Hospital Muenster, Albert-Schweitzer-Str. 33, 48149, Münster, Germany.
Uebing A; Department of Congenital Heart Disease and Pediatric Cardiology, University Hospital Schleswig-Holstein, Campus Kiel, Arnold-Heller-Str. 3, 24105, Kiel, Germany.
Nürnberg JH; Electrophysiology Bremen, Heart Center Bremen, Bremen, Germany.
Hebe J; Electrophysiology Bremen, Heart Center Bremen, Bremen, Germany.
Pokaż więcej
Transliterated Title :
Antiarrhythmika – Sicherheit und Wirksamkeit in der Schwangerschaft.
Źródło :
Herzschrittmachertherapie & Elektrophysiologie [Herzschrittmacherther Elektrophysiol] 2021 Jun; Vol. 32 (2), pp. 145-151. Date of Electronic Publication: 2021 Mar 29.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Anti-Arrhythmia Agents*/adverse effects
Tachycardia, Supraventricular*/drug therapy
Female ; Humans ; Pregnancy
Czasopismo naukowe
Tytuł :
Antiarrhythmic Hit to Lead Refinement in a Dish Using Patient-Derived iPSC Cardiomyocytes.
Autorzy :
Cashman JR; Human BioMolecular Research Institute, San Diego, California 92121, United States.
Ryan D; Human BioMolecular Research Institute, San Diego, California 92121, United States.
McKeithan WL; Cardiovascular Institute and Department of Medicine, Stanford University, Stanford, California 94305, United States.; Graduate School of Biomedical Sciences, Sanford Burnham Prebys Medical Discovery Institute, San Diego, California 92037, United States.
Okolotowicz K; Human BioMolecular Research Institute, San Diego, California 92121, United States.
Gomez-Galeno J; Human BioMolecular Research Institute, San Diego, California 92121, United States.
Johnson M; Human BioMolecular Research Institute, San Diego, California 92121, United States.
Sampson KJ; Department of Pharmacology, College of Physicians and Surgeons, Columbia University, New York, New York 10032, United States.
Kass RS; Department of Pharmacology, College of Physicians and Surgeons, Columbia University, New York, New York 10032, United States.
Pezhouman A; Division of Cardiology, Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California 90095, United States.
Karagueuzian HS; Division of Cardiology, Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California 90095, United States.
Mercola M; Cardiovascular Institute and Department of Medicine, Stanford University, Stanford, California 94305, United States.; Graduate School of Biomedical Sciences, Sanford Burnham Prebys Medical Discovery Institute, San Diego, California 92037, United States.
Pokaż więcej
Źródło :
Journal of medicinal chemistry [J Med Chem] 2021 May 13; Vol. 64 (9), pp. 5384-5403. Date of Electronic Publication: 2021 May 04.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Anti-Arrhythmia Agents/*chemistry
Cardiac Conduction System Disease/*pathology
Long QT Syndrome/*pathology
Mexiletine/*analogs & derivatives
Action Potentials/drug effects ; Animals ; Anti-Arrhythmia Agents/pharmacology ; Behavior, Animal/drug effects ; Cardiac Conduction System Disease/metabolism ; Cells, Cultured ; Drug Design ; Drug Stability ; Half-Life ; Humans ; Induced Pluripotent Stem Cells/cytology ; Induced Pluripotent Stem Cells/metabolism ; Long QT Syndrome/metabolism ; Male ; Mexiletine/pharmacology ; Mice ; Mice, Inbred BALB C ; Myocytes, Cardiac/cytology ; Myocytes, Cardiac/drug effects ; Myocytes, Cardiac/physiology ; NAV1.5 Voltage-Gated Sodium Channel/genetics ; NAV1.5 Voltage-Gated Sodium Channel/metabolism ; Rats ; Rats, Sprague-Dawley ; Structure-Activity Relationship
SCR Disease Name :
Long QT syndrome type 3
Czasopismo naukowe
Tytuł :
Structural Basis for Pore Blockade of the Human Cardiac Sodium Channel Na v 1.5 by the Antiarrhythmic Drug Quinidine*.
Autorzy :
Li Z; State Key Laboratory of Membrane Biology, Beijing Advanced Innovation Center for Structural Biology, Tsinghua-Peking Joint Center for Life Science, School of Life Sciences, Tsinghua University, Beijing, 100084, China.
Jin X; State Key Laboratory of Membrane Biology, Beijing Advanced Innovation Center for Structural Biology, Tsinghua-Peking Joint Center for Life Science, School of Life Sciences, Tsinghua University, Beijing, 100084, China.
Wu T; State Key Laboratory of Membrane Biology, Beijing Advanced Innovation Center for Structural Biology, Tsinghua-Peking Joint Center for Life Science, School of Life Sciences, Tsinghua University, Beijing, 100084, China.
Huang G; Key Laboratory of Structural Biology of Zhejiang Province, Institute of Biology, Westlake Institute for Advanced Study, School of Life Sciences, Westlake University, Hangzhou, 310024, Zhejiang Province, China.
Wu K; Medical Research Center, Beijing Key Laboratory of Cardiopulmonary Cerebral Resuscitation, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, 100020, China.
Lei J; Technology Center for Protein Sciences, Ministry of Education Key Laboratory of Protein Sciences, School of Life Sciences, Tsinghua University, Beijing, 100084, China.
Pan X; State Key Laboratory of Membrane Biology, Beijing Advanced Innovation Center for Structural Biology, Tsinghua-Peking Joint Center for Life Science, School of Life Sciences, Tsinghua University, Beijing, 100084, China.
Yan N; Department of Molecular Biology, Princeton University, Princeton, NJ, 08544, USA.
Pokaż więcej
Źródło :
Angewandte Chemie (International ed. in English) [Angew Chem Int Ed Engl] 2021 May 10; Vol. 60 (20), pp. 11474-11480. Date of Electronic Publication: 2021 Apr 06.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Anti-Arrhythmia Agents/*pharmacology
NAV1.5 Voltage-Gated Sodium Channel/*metabolism
Quinidine/*pharmacology
Anti-Arrhythmia Agents/chemistry ; Cryoelectron Microscopy ; Humans ; Models, Molecular ; NAV1.5 Voltage-Gated Sodium Channel/chemistry ; Quinidine/chemistry
Czasopismo naukowe
Tytuł :
A frightening giant QRS complex in a 3-months-old infant.
Autorzy :
Correra A; Adult Congenital Heart Disease Unit, Monaldi Hospital, Naples, Italy. Electronic address: .
Merola A; Adult Congenital Heart Disease Unit, Monaldi Hospital, Naples, Italy; Paediatric Cardiology Unit, 'L.Vanvitelli' University - Monaldi Hospital, Naples, Italy.
Palma M; Adult Congenital Heart Disease Unit, Monaldi Hospital, Naples, Italy; Paediatric Cardiology Unit, 'L.Vanvitelli' University - Monaldi Hospital, Naples, Italy.
Romeo E; Adult Congenital Heart Disease Unit, Monaldi Hospital, Naples, Italy.
Colonna D; Adult Congenital Heart Disease Unit, Monaldi Hospital, Naples, Italy; Paediatric Cardiology Unit, 'L.Vanvitelli' University - Monaldi Hospital, Naples, Italy.
Passariello A; Paediatric Cardiology Unit, 'L.Vanvitelli' University - Monaldi Hospital, Naples, Italy.
Russo MG; Paediatric Cardiology Unit, 'L.Vanvitelli' University - Monaldi Hospital, Naples, Italy.
Sarubbi B; Adult Congenital Heart Disease Unit, Monaldi Hospital, Naples, Italy.
Pokaż więcej
Źródło :
Journal of electrocardiology [J Electrocardiol] 2021 May-Jun; Vol. 66, pp. 16-17. Date of Electronic Publication: 2020 Jul 30.
Typ publikacji :
Journal Article
MeSH Terms :
Anti-Arrhythmia Agents*/therapeutic use
Drug Overdose*
Electrocardiography ; Flecainide ; Humans ; Infant
Czasopismo naukowe
Tytuł :
Protective Effects of 3,4-Seco-Lupane Triterpenes from Food Raw Materials of the Leaves of Eleutherococcus Senticosus and Eleutherococcus Sessiliflorus on Arrhythmia Induced by Barium Chloride.
Autorzy :
Zhao Y; College of Chinese Medicinal Materials, Jilin Agricultural University, Changchun, 130118, P. R. China.
Wang X; College of Chinese Medicinal Materials, Jilin Agricultural University, Changchun, 130118, P. R. China.
Chen C; College of Chinese Medicinal Materials, Jilin Agricultural University, Changchun, 130118, P. R. China.
Shi K; College of Chinese Medicinal Materials, Jilin Agricultural University, Changchun, 130118, P. R. China.
Li J; College of Chinese Medicinal Materials, Jilin Agricultural University, Changchun, 130118, P. R. China.
Du R; College of Chinese Medicinal Materials, Jilin Agricultural University, Changchun, 130118, P. R. China.; Jilin Provincial Engineering Research Center for Efficient Breeding and Product Development of Sika Deer, Changchun, 130118, P. R. China.; Key Laboratory of Animal Production and Product Quality and Security, Ministry of Education, Changchun, 130118, P. R. China.
Pokaż więcej
Źródło :
Chemistry & biodiversity [Chem Biodivers] 2021 Apr; Vol. 18 (4), pp. e2001021. Date of Electronic Publication: 2021 Mar 31.
Typ publikacji :
Journal Article
MeSH Terms :
Anti-Arrhythmia Agents/*pharmacology
Arrhythmias, Cardiac/*drug therapy
Eleutherococcus/*chemistry
Plant Extracts/*pharmacology
Protective Agents/*pharmacology
Triterpenes/*pharmacology
Animals ; Anti-Arrhythmia Agents/chemistry ; Anti-Arrhythmia Agents/isolation & purification ; Apoptosis/drug effects ; Arrhythmias, Cardiac/chemically induced ; Arrhythmias, Cardiac/metabolism ; Barium Compounds ; Cell Line ; Cell Proliferation/drug effects ; Cell Survival/drug effects ; Chlorides ; Disease Models, Animal ; Male ; Molecular Conformation ; Molecular Docking Simulation ; Plant Extracts/chemistry ; Plant Extracts/isolation & purification ; Plant Leaves/chemistry ; Protective Agents/chemistry ; Protective Agents/isolation & purification ; Rats ; Rats, Wistar ; Triterpenes/chemistry ; Triterpenes/isolation & purification
Czasopismo naukowe
Tytuł :
Ranolazine in the prevention and treatment of atrial fibrillation: A protocol for meta-analysis.
Autorzy :
Yuan C; Department of Pharmacy, Baoji Traditional Chinese Medicine Hospital, Baoji, Shanxi.
Luo W; The Second School of Clinical Medicine.
Ren X; The Second School of Clinical Medicine.
Ya M; The Second School of Clinical Medicine.
Yan W; The First School of Clinical Medicine, Lanzhou University.
Hui Q; Baoji People's Hospital, Baoji, Shanxi, China.
Pokaż więcej
Źródło :
Medicine [Medicine (Baltimore)] 2021 Apr 23; Vol. 100 (16), pp. e25437.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Anti-Arrhythmia Agents/*administration & dosage
Atrial Fibrillation/*drug therapy
Ranolazine/*administration & dosage
Secondary Prevention/*methods
Sodium Channel Blockers/*administration & dosage
Anti-Arrhythmia Agents/adverse effects ; Atrial Fibrillation/mortality ; Atrial Fibrillation/prevention & control ; Humans ; Meta-Analysis as Topic ; Placebos/administration & dosage ; Placebos/adverse effects ; Randomized Controlled Trials as Topic ; Recurrence ; Risk Assessment ; Sodium Channel Blockers/adverse effects ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Supraventricular tachycardias in the first year of life: what is the best pharmacological treatment? 24 years of experience in a single centre.
Autorzy :
Capponi G; Department of Health Sciences, Post-Graduate School of Paediatrics, Anna Meyer Children's University Hospital, Florence, Italy.
Belli G; Department of Health Sciences, Post-Graduate School of Paediatrics, Anna Meyer Children's University Hospital, Florence, Italy.
Giovannini M; Department of Health Sciences, Post-Graduate School of Paediatrics, Anna Meyer Children's University Hospital, Florence, Italy.
Remaschi G; Neonatology Department and Neonatal Intensive Care Unit, Careggi University Hospital, Florence, Italy.
Brambilla A; Cardiology Unit, Anna Meyer Children's University Hospital, Viale Gaetano Pieraccini 24, 50139, Florence, Italy.
Vannuccini F; Cardiology Unit, Anna Meyer Children's University Hospital, Viale Gaetano Pieraccini 24, 50139, Florence, Italy.
Favilli S; Cardiology Unit, Anna Meyer Children's University Hospital, Viale Gaetano Pieraccini 24, 50139, Florence, Italy.
Porcedda G; Cardiology Unit, Anna Meyer Children's University Hospital, Viale Gaetano Pieraccini 24, 50139, Florence, Italy.
De Simone L; Cardiology Unit, Anna Meyer Children's University Hospital, Viale Gaetano Pieraccini 24, 50139, Florence, Italy. .
Pokaż więcej
Źródło :
BMC cardiovascular disorders [BMC Cardiovasc Disord] 2021 Mar 15; Vol. 21 (1), pp. 137. Date of Electronic Publication: 2021 Mar 15.
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
Anti-Arrhythmia Agents/*therapeutic use
Heart Rate/*drug effects
Tachycardia, Supraventricular/*drug therapy
Action Potentials ; Adrenergic beta-Antagonists/therapeutic use ; Age Factors ; Anti-Arrhythmia Agents/adverse effects ; Digoxin/therapeutic use ; Drug Therapy, Combination ; Female ; Flecainide/therapeutic use ; Humans ; Infant ; Infant, Newborn ; Male ; Nadolol/therapeutic use ; Recurrence ; Retrospective Studies ; Sotalol/therapeutic use ; Tachycardia, Supraventricular/diagnosis ; Tachycardia, Supraventricular/physiopathology ; Time Factors ; Treatment Outcome ; Voltage-Gated Sodium Channel Blockers/therapeutic use
Czasopismo naukowe
Tytuł :
New methodological approaches to atrial fibrillation drug discovery.
Autorzy :
Wong CK; Cardiology Division, Department of Medicine, The University of Hong Kong, Hong Kong, SAR China.
Tse HF; Cardiology Division, Department of Medicine, The University of Hong Kong, Hong Kong, SAR China.
Pokaż więcej
Źródło :
Expert opinion on drug discovery [Expert Opin Drug Discov] 2021 Mar; Vol. 16 (3), pp. 319-329. Date of Electronic Publication: 2020 Oct 05.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Anti-Arrhythmia Agents/*pharmacology
Atrial Fibrillation/*drug therapy
Drug Discovery/*methods
Animals ; Anti-Arrhythmia Agents/adverse effects ; Atrial Fibrillation/physiopathology ; Drug Development/methods ; Genetic Therapy/methods ; Humans ; Molecular Targeted Therapy ; Stem Cells/cytology ; Tissue Engineering/methods
Czasopismo naukowe
Tytuł :
Management of Arrhythmias After Heart Transplant: Current State and Considerations for Future Research.
Autorzy :
Joglar JA; Department of Internal Medicine, Division of Cardiology, University of Texas Southwestern Medical Center, Dallas (J.A.J., M.L., M.D.).
Wan EY; Division of Cardiology, Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY (E.Y.W.).
Chung MK; Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, OH (M.K.C.).; Department of Cardiovascular Medicine, Icahn School of Medicine at Mount Sinai, New York, NY (M.K.T.).
Gutierrez A; Department of Medicine, University of Minnesota, Minneapolis (A.G.).
Slaughter MS; Department of Cardiovascular and Thoracic Surgery, University of Louisville, KY (M.S.S., B.P.B.).
Bateson BP; Department of Cardiovascular and Thoracic Surgery, University of Louisville, KY (M.S.S., B.P.B.).
Loguidice M; Department of Internal Medicine, Division of Cardiology, University of Texas Southwestern Medical Center, Dallas (J.A.J., M.L., M.D.).
Drazner M; Department of Internal Medicine, Division of Cardiology, University of Texas Southwestern Medical Center, Dallas (J.A.J., M.L., M.D.).
Kistler PM; Heart Centre, The Alfred Hospital, Melbourne, Australia (P.M.K.).
Saour B; Department of Internal Medicine, University of Washington, Seattle (B.S., J.E.P.).
Poole JE; Department of Internal Medicine, University of Washington, Seattle (B.S., J.E.P.).
Murtaza G; Kansas City Heart Rhythm Institute and Research Foundation, Overland Park, KS (G.M., D.L., R.G.).
Turagam MK
Vader J; Department of Internal Medicine, Cardiovascular Division, Washington University School of Medicine, St. Louis, MO (J.V.).
Lakkireddy D; Kansas City Heart Rhythm Institute and Research Foundation, Overland Park, KS (G.M., D.L., R.G.).
Birati EY; Advanced Heart Failure/Transplantation Program, Division of Cardiovascular Medicine, Department of Internal Medicine, Perelman School of Medicine, Philadelphia, PA (E.Y.B.).
Dhingra R; Advanced Heart Disease and Transplant, Division of Cardiology, University of Wisconsin, Madison (R.D.).
Gopinathannair R; Kansas City Heart Rhythm Institute and Research Foundation, Overland Park, KS (G.M., D.L., R.G.).
Pokaż więcej
Źródło :
Circulation. Arrhythmia and electrophysiology [Circ Arrhythm Electrophysiol] 2021 Mar; Vol. 14 (3), pp. e007954. Date of Electronic Publication: 2021 Mar 09.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Catheter Ablation*/adverse effects
Catheter Ablation*/mortality
Electric Countershock*/adverse effects
Electric Countershock*/instrumentation
Electric Countershock*/mortality
Anti-Arrhythmia Agents/*therapeutic use
Arrhythmias, Cardiac/*therapy
Heart Rate/*drug effects
Heart Transplantation/*adverse effects
Action Potentials ; Animals ; Anti-Arrhythmia Agents/adverse effects ; Arrhythmias, Cardiac/etiology ; Arrhythmias, Cardiac/mortality ; Arrhythmias, Cardiac/physiopathology ; Defibrillators, Implantable ; Heart Transplantation/mortality ; Humans ; Risk Factors ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Perioperative Beta-Blocker for Atrial Fibrillation after Cardiac Surgery: A Meta-Analysis.
Autorzy :
Kim SH; Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul, the Republic of Korea.
Jang MJ; Medical Research Collaborating Center, Seoul National University Hospital, Seoul, the Republic of Korea.
Hwang HY; Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul, the Republic of Korea.
Pokaż więcej
Źródło :
The Thoracic and cardiovascular surgeon [Thorac Cardiovasc Surg] 2021 Mar; Vol. 69 (2), pp. 133-140. Date of Electronic Publication: 2020 Apr 06.
Typ publikacji :
Journal Article; Meta-Analysis; Systematic Review
MeSH Terms :
Perioperative Care*/adverse effects
Adrenergic beta-Antagonists/*administration & dosage
Anti-Arrhythmia Agents/*administration & dosage
Atrial Fibrillation/*prevention & control
Cardiac Surgical Procedures/*adverse effects
Heart Rate/*drug effects
Adrenergic beta-Antagonists/adverse effects ; Aged ; Anti-Arrhythmia Agents/adverse effects ; Atrial Fibrillation/diagnosis ; Atrial Fibrillation/etiology ; Atrial Fibrillation/physiopathology ; Drug Administration Schedule ; Female ; Humans ; Male ; Middle Aged ; Risk Assessment ; Risk Factors ; Time Factors ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Amiodarone and hypothyroidism.
Autorzy :
Christidis G; Department of Medicine II, Saarland University Medical Centre, Saarland University, Homburg, Germany.
Lammert F; Department of Medicine II, Saarland University Medical Centre, Saarland University, Homburg, Germany.
Krawczyk M; Department of Medicine II, Saarland University Medical Centre, Saarland University, Homburg, Germany; Laboratory of Metabolic Liver Diseases, Center for Preclinical Research, Department of General, Transplant and Liver Surgery, Medical University of Warsaw, Warsaw, Poland. Electronic address: .
Pokaż więcej
Źródło :
Lancet (London, England) [Lancet] 2021 Feb 20; Vol. 397 (10275), pp. 704.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Amiodarone/*adverse effects
Anti-Arrhythmia Agents/*adverse effects
Hypothyroidism/*chemically induced
Tachycardia, Ventricular/*drug therapy
Aged ; Amiodarone/administration & dosage ; Anti-Arrhythmia Agents/administration & dosage ; Humans ; Male
Czasopismo naukowe
Tytuł :
Using Spectrum-Effect Relationships Coupled with LC-TOF-MS to Screen Anti-arrhythmic Components of the Total Flavonoids in Hypericum attenuatum Extracts.
Autorzy :
Feng Y; Laboratory of Chinese Materia Medica in Ministry of Education, Heilongjiang University of Chinese Medicine, Harbin 150040, China.
Teng L; The Second Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin 150040, China.
Wang Y; Heilongjiang Nursing College, Harbin 150030, China.
Gao Y; Dentistry Teaching and Research Office, Heilongjiang University of Chinese Medicine, Harbin 150040, China.
Ma Y; Dentistry Teaching and Research Office, Heilongjiang University of Chinese Medicine, Harbin 150040, China.
Zhou H; The Second Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin 150040, China.
Cai G; The Second Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin 150040, China.
Li J; Dentistry Teaching and Research Office, Heilongjiang University of Chinese Medicine, Harbin 150040, China.
Pokaż więcej
Źródło :
Journal of chromatographic science [J Chromatogr Sci] 2021 Feb 15; Vol. 59 (3), pp. 246-261.
Typ publikacji :
Journal Article
MeSH Terms :
Anti-Arrhythmia Agents/*analysis
Chromatography, High Pressure Liquid/*methods
Drug Discovery/*methods
Flavonoids/*analysis
Hypericum/*chemistry
Anti-Arrhythmia Agents/chemistry ; Flavonoids/chemistry ; Mass Spectrometry/methods ; Plant Extracts/chemistry
Czasopismo naukowe
Tytuł :
Comparison of sustained rate control in atrial fibrillation with rapid ventricular rate: Metoprolol vs. Diltiazem.
Autorzy :
Hargrove KL; University Health, San Antonio, TX 78229, United States; University of Texas Health San Antonio, Pharmacotherapy Education & Research Center, San Antonio, TX 78229, United States; The University of Texas at Austin, College of Pharmacy, Austin, TX 78712, United States; University of the Incarnate Word, Feik School of Pharmacy, San Antonio, TX 78209, United States. Electronic address: .
Robinson EE; University Health, San Antonio, TX 78229, United States; University of Texas Health San Antonio, Pharmacotherapy Education & Research Center, San Antonio, TX 78229, United States; The University of Texas at Austin, College of Pharmacy, Austin, TX 78712, United States; University of the Incarnate Word, Feik School of Pharmacy, San Antonio, TX 78209, United States.
Lusk KA; University Health, San Antonio, TX 78229, United States; University of Texas Health San Antonio, Pharmacotherapy Education & Research Center, San Antonio, TX 78229, United States; University of the Incarnate Word, Feik School of Pharmacy, San Antonio, TX 78209, United States.
Hughes DW; University Health, San Antonio, TX 78229, United States; University of Texas Health San Antonio, Pharmacotherapy Education & Research Center, San Antonio, TX 78229, United States; The University of Texas at Austin, College of Pharmacy, Austin, TX 78712, United States.
Neff LA; University Health, San Antonio, TX 78229, United States; University of Texas Health San Antonio, Pharmacotherapy Education & Research Center, San Antonio, TX 78229, United States; The University of Texas at Austin, College of Pharmacy, Austin, TX 78712, United States; University of the Incarnate Word, Feik School of Pharmacy, San Antonio, TX 78209, United States.
Fowler AL; University Health, San Antonio, TX 78229, United States; University of Texas Health San Antonio, Pharmacotherapy Education & Research Center, San Antonio, TX 78229, United States; The University of Texas at Austin, College of Pharmacy, Austin, TX 78712, United States; University of the Incarnate Word, Feik School of Pharmacy, San Antonio, TX 78209, United States.
Pokaż więcej
Źródło :
The American journal of emergency medicine [Am J Emerg Med] 2021 Feb; Vol. 40, pp. 15-19. Date of Electronic Publication: 2020 Dec 03.
Typ publikacji :
Comparative Study; Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Emergency Service, Hospital*
Anti-Arrhythmia Agents/*therapeutic use
Atrial Fibrillation/*drug therapy
Cardiovascular Agents/*therapeutic use
Diltiazem/*therapeutic use
Heart Rate/*drug effects
Metoprolol/*therapeutic use
Anti-Arrhythmia Agents/administration & dosage ; Cardiovascular Agents/administration & dosage ; Diltiazem/administration & dosage ; Female ; Humans ; Male ; Metoprolol/administration & dosage ; Middle Aged ; Retrospective Studies ; Texas
Czasopismo naukowe
Tytuł :
Atrial fibrillation in obstructive sleep apnea: Neural mechanisms and emerging therapies.
Autorzy :
Huang B; Department of Cardiology, Renmin Hospital of Wuhan University, No. 238 Jiefang Road, Wuchang District, Wuhan, Hubei 430060, PR China; Department of Cardiology, Fifth Affiliated Hospital of Xinjiang Medical University, No. 118 Henan Road, Xinshi District, Urumqi, Xinjiang 830000, PR China; Cardiovascular Research Institute, Wuhan University, Wuhan, Hubei, PR China; Hubei Key Laboratory of Cardiology, Wuhan, Hubei, PR China.
Liu H; Department of Cardiology, Renmin Hospital of Wuhan University, No. 238 Jiefang Road, Wuchang District, Wuhan, Hubei 430060, PR China; Cardiovascular Research Institute, Wuhan University, Wuhan, Hubei, PR China; Hubei Key Laboratory of Cardiology, Wuhan, Hubei, PR China.
Scherlag BJ; Heart Rhythm Institute and Department of Medicine, University of Oklahoma Health Science Center, Oklahoma City, OK, United States.
Sun L; Department of Cardiology, Fifth Affiliated Hospital of Xinjiang Medical University, No. 118 Henan Road, Xinshi District, Urumqi, Xinjiang 830000, PR China.
Xing S; Department of Cardiology, Fifth Affiliated Hospital of Xinjiang Medical University, No. 118 Henan Road, Xinshi District, Urumqi, Xinjiang 830000, PR China.
Xu J; Department of Cardiology, Fifth Affiliated Hospital of Xinjiang Medical University, No. 118 Henan Road, Xinshi District, Urumqi, Xinjiang 830000, PR China.
Luo M; Department of Cardiology, Fifth Affiliated Hospital of Xinjiang Medical University, No. 118 Henan Road, Xinshi District, Urumqi, Xinjiang 830000, PR China.
Guo Y; Department of Cardiology, Fifth Affiliated Hospital of Xinjiang Medical University, No. 118 Henan Road, Xinshi District, Urumqi, Xinjiang 830000, PR China.
Cao G; Department of Cardiology, Fifth Affiliated Hospital of Xinjiang Medical University, No. 118 Henan Road, Xinshi District, Urumqi, Xinjiang 830000, PR China. Electronic address: .
Jiang H; Department of Cardiology, Renmin Hospital of Wuhan University, No. 238 Jiefang Road, Wuchang District, Wuhan, Hubei 430060, PR China; Cardiovascular Research Institute, Wuhan University, Wuhan, Hubei, PR China; Hubei Key Laboratory of Cardiology, Wuhan, Hubei, PR China. Electronic address: .
Pokaż więcej
Źródło :
Trends in cardiovascular medicine [Trends Cardiovasc Med] 2021 Feb; Vol. 31 (2), pp. 127-132. Date of Electronic Publication: 2020 Jan 22.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Autonomic Denervation*/adverse effects
Catheter Ablation*/adverse effects
Vagus Nerve Stimulation*/adverse effects
Anti-Arrhythmia Agents/*therapeutic use
Atrial Fibrillation/*therapy
Autonomic Nervous System/*physiopathology
Heart/*innervation
Renal Artery/*innervation
Sleep Apnea, Obstructive/*therapy
Animals ; Anti-Arrhythmia Agents/adverse effects ; Atrial Fibrillation/diagnosis ; Atrial Fibrillation/physiopathology ; Continuous Positive Airway Pressure ; Electric Countershock ; Humans ; Sleep Apnea, Obstructive/diagnosis ; Sleep Apnea, Obstructive/physiopathology ; Treatment Outcome
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies